The myelin oligodendrocyte glycoprotein (MOG) is a component of myelin sheets, located on the extracellular surface of mature oligodendrocytes. Serum anti-MOG antibodies have been found in multiple acquired demyelinating syndromes, encompassing heterogeneous clinical manifestations such as optic neuritis (ON), transverse myelitis (TM) or their combination, brainstem involvement, and acute disseminated encephalomyelitis (ADEM).
CITATION STYLE
Filippi, M., & Rocca, M. A. (2020). Anti-MOG Diseases. In White Matter Diseases (pp. 95–108). Springer International Publishing. https://doi.org/10.1007/978-3-030-38621-4_4
Mendeley helps you to discover research relevant for your work.